---
title: CHF Management Using Telemedicine
nct_id: NCT00309764
overall_status: COMPLETED
phase: NA
sponsor: Kaiser Permanente
study_type: INTERVENTIONAL
primary_condition: Congestive Heart Failure (CHF)
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00309764.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00309764"
ct_last_update_post_date: 2006-04-03
last_seen_at: "2026-05-12T07:23:27.285Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# CHF Management Using Telemedicine

**Official Title:** Improving CHF Outcomes Through Interactive Voice Recognition (IVR) Data Acquisition and Targeted Nurse Follow-Up

**NCT ID:** [NCT00309764](https://clinicaltrials.gov/study/NCT00309764)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 106
- **Lead Sponsor:** Kaiser Permanente
- **Collaborators:** Robert Wood Johnson Foundation
- **Conditions:** Congestive Heart Failure (CHF)
- **Start Date:** 2001-11
- **Completion Date:** 2002-08
- **CT.gov Last Update:** 2006-04-03

## Brief Summary

The overall objective of this study is to improve clinical outcomes and quality of life for congestive heart failure (CHF) patients by integrating a readily available, low cost technology - the telephone - into coordinated CHF care.

## Detailed Description

Strong patient-provider communication and vigilant home-based monitoring can be critical elements of successful chronic disease management. Among CHF patients, automated clinical data acquisition via the telephone can improve insight into inappropriate use of medications and onset of fluid overload or edema - indicating deteriorating heart function (notably worsening ejection fraction). Routine, timely monitoring of this data can direct a nurse case manager to the subset of CHF patients likely to benefit from a clinic visit, evaluation, diagnosis, and counseling. This should result in: significantly increased medication compliance, significantly lower emergency department (ED) visits and hospital admissions (both those related to CHF and other conditions related to diminished physical capacity of patients with CHF), and improved physical function.

This study is intended to answer three questions. First, do potentially avoidable acute events (measured by ED visits and hospital admissions) decrease when CHF management is accompanied by systematic telephone-based monitoring as compared with usual care? Second, does medication compliance improve when CHF management is accompanied by systematic telephone-based monitoring as compared with usual care? Third, does perceived health status (physical and emotional function) improve when CHF management is accompanied by systematic telephone-based monitoring as compared with usual care?

## Eligibility

- **Minimum age:** 30 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* Physician diagnosed CHF
* Member of Kaiser Permanente Georgia
```

## Interventions

- **Telemedicine** (BEHAVIORAL)

## Primary Outcomes

- **Change between study entry and exit (6-months later) in frequency of recommended CHF self-care practices (maintain CHF diary, check weight daily, check ankles and feet for swelling daily)**
- **Knowledge of signs of worsening CHF (sudden weight gain, increase in shortness of breath)**
- **Quality of life**

## Secondary Outcomes

- **Rate of acute CHF exacerbations (ED visits or hospital admissions for CHF or CHF-related conditions) in the 6-month intervention period compared with the 6-month period preceding study entry.**

## Locations (1)

- Kaiser Permanente - Georgia, Atlanta, Georgia, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.kaiser permanente - georgia|atlanta|georgia|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00309764.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00309764*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*